SCHEMBL3482701

SCHEMBL3482701

O=C(/C=C/C(=O)OCCc1ccccc1)OCCc1ccccc1

nearest known ligand 0.89

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HCAR2 Q8TDS4 2/20 0.89
AKR1B10 O60218 6/20 0.77
AKR1B1 P15121 6/20 0.77
MAOB P27338 1/20 0.69
ALOX5 P09917 4/20 0.63
TTR P02766 4/20 0.63
CYP3A4 P08684 2/20 0.63
ALOX15 P16050 2/20 0.63
ALOX12 P18054 2/20 0.63
MAPK1 P28482 2/20 0.63
HSD17B10 Q99714 2/20 0.63
KDM4E B2RXH2 1/20 0.63
MEN1 O00255 1/20 0.63
GMNN O75496 1/20 0.63
ALDH1A1 P00352 1/20 0.63
EGFR P00533 1/20 0.63
LMNA P02545 1/20 0.63
ESR1 P03372 1/20 0.63
ERBB2 P04626 1/20 0.63
APP P05067 1/20 0.63

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL573377 1.00 HCAR2 (0.89) HCAR2AKR1B10AKR1B1MAOBALOX5
SCHEMBL9860306 1.00 HCAR2 (0.89) HCAR2AKR1B10AKR1B1MAOBALOX5
Phenylethyl Fumarate SCHEMBL573376 0.94 HCAR2 (1.00) HCAR2AKR1B10AKR1B1MAOBALOX5
Phenylethyl Fumarate SCHEMBL27750209 0.94 HCAR2 (1.00) HCAR2AKR1B10AKR1B1MAOBALOX5
Phenylethyl Fumarate SCHEMBL573379 0.94 HCAR2 (1.00) HCAR2AKR1B10AKR1B1MAOBALOX5
SCHEMBL25623741 0.91 HCAR2 (0.76) HCAR2AKR1B10AKR1B1MAOBALOX5
SCHEMBL27735855 0.91 HCAR2 (0.76) HCAR2AKR1B10AKR1B1MAOBALOX5
SCHEMBL7268059 0.91 HCAR2 (0.76) HCAR2AKR1B10AKR1B1MAOBALOX5
SCHEMBL23343675 0.91 HCAR2 (0.75) HCAR2AKR1B10AKR1B1MAOBALOX5
SCHEMBL29839413 0.90 HCAR2 (0.73) HCAR2AKR1B10AKR1B1MAOBALOX5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101346341-A Improvements in or related to organic compoounds GIVAUDAN SA (CH) 2009-01-14 CN claimed
EP-0233299-B1 OPTICAL RESIN AND PROCESS FOR PREPARING THE SAME NIPPON OIL AND FATS COMPANY, LIMITED (JP) 1991-03-13 EP claimed
US-4855374-A Optical resin from diallyl esters NIPPON OIL AND FATS CO., LTD. (JP) 1989-08-08 US claimed
EP-0233299-A1 Optical resin and process for preparing the same NIPPON OIL AND FATS COMPANY, LIMITED (JP) 1987-08-26 EP claimed
US-8420764-B2 Compound having silsesquioxane skeleton and its polymer JNC CORPORATION (JP) 2013-04-16 US disclosed
US-20120178894-A1 COMPOUND HAVING SILSESQUIOXANE SKELETON AND ITS POLYMER INAGAKI JYUN-ICHI (JP) 2012-07-12 US disclosed
CN-102372633-A Preparation method of antiseptic mono-benzyl-methyl fumarate UNIV JIANGSU 2012-03-14 CN disclosed
CN-102372633-A Preparation method of antiseptic mono-benzyl-methyl fumarate UNIV JIANGSU 2012-03-14 CN disclosed
US-7705105-B2 A cyclic polymer of silsesquioxane skeleton with side chains formed byhydrosilation of an unsaturated end group containing an active polymerfunctional group; polyimidesiloxane copolymers; polyestersiloxane copolymers; high molecular weight; thin films; strength; heat resistance;waterproofing; CHISSO PETROCHEMICAL CORPORATION (JP) 2010-04-27 US disclosed
CN-101346341-A Improvements in or related to organic compoounds GIVAUDAN SA (CH) 2009-01-14 CN disclosed
US-20070190344-A1 Verification of translation JNC CORPORATION (JP) 2007-08-16 US disclosed
US-20050009982-A1 Compound having silsesquioxane skeleton and its polymer CHISSO CORPORATION (JP) 2005-01-13 US disclosed
EP-0233299-B1 OPTICAL RESIN AND PROCESS FOR PREPARING THE SAME NIPPON OIL AND FATS COMPANY, LIMITED (JP) 1991-03-13 EP disclosed
US-4855374-A Optical resin from diallyl esters NIPPON OIL AND FATS CO., LTD. (JP) 1989-08-08 US disclosed
EP-0233299-A1 Optical resin and process for preparing the same NIPPON OIL AND FATS COMPANY, LIMITED (JP) 1987-08-26 EP disclosed
EP-0017927-B1 PROCESS FOR PREPARING PHOTOPOLYMERIZED ELASTOMERIC PRINTING PLATES NOT DISPLAYING SURFACE STICKINESS Asahi Kasei Kogyo Kabushiki Kaisha (JP) 1984-09-19 EP disclosed
US-4468453-A Dry process for forming an image ASAHI KASEI KOGYO KABUSHIKI KAISHA (JP) 1984-08-28 US disclosed
US-4266005-A Photosensitive elastomeric composition ASAHI KASEI KOGYO KABUSHIKI KAISHA (JP) 1981-05-05 US disclosed
EP-0017927-A2 Process for preparing photopolymerized elastomeric printing plates not displaying surface stickiness Asahi Kasei Kogyo Kabushiki Kaisha (JP) 1980-10-29 EP disclosed
US-4197130-A Photosensitive elastomeric composition and element ASAHI KASEI KOGYO KABUSHIKI KAISHA (JP) 1980-04-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050009982-A1 Compound having silsesquioxane skeleton and its polymer C1S, H1-4, H1-0 HCAR2 2928/4885AKR1B10 2310/4885AKR1B1 1778/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.